These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38570586)
21. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance]. Jing CX; Feng Y; Cao X; Xu CG Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142 [TBL] [Abstract][Full Text] [Related]
22. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857 [TBL] [Abstract][Full Text] [Related]
23. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas. Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898 [TBL] [Abstract][Full Text] [Related]
26. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893 [TBL] [Abstract][Full Text] [Related]
27. Molecular Pathogenesis of Mantle Cell Lymphoma. Navarro A; Beà S; Jares P; Campo E Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma. Jing C; Zheng Y; Feng Y; Cao X; Xu C Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776 [TBL] [Abstract][Full Text] [Related]
29. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma. Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831 [TBL] [Abstract][Full Text] [Related]
30. SOX11 inhibits tumor proliferation and promotes cell adhesion mediated-drug resistance via a CD43 dependent manner in mantle cell lymphoma. Yang R; Huo Z; Duan Y; Tong W; Zheng Y; Su Y; Lou L; Zhang Q; Xu S; Peng C; Kuang D; Wang G Leuk Lymphoma; 2020 Sep; 61(9):2068-2081. PubMed ID: 32449421 [TBL] [Abstract][Full Text] [Related]
31. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557 [TBL] [Abstract][Full Text] [Related]
32. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma. He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407 [TBL] [Abstract][Full Text] [Related]
33. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440 [TBL] [Abstract][Full Text] [Related]
34. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Abdelrazak Morsy MH; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B Blood; 2024 May; 143(19):1953-1964. PubMed ID: 38237141 [TBL] [Abstract][Full Text] [Related]
35. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma. Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312 [TBL] [Abstract][Full Text] [Related]
36. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760 [TBL] [Abstract][Full Text] [Related]
37. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma. Kuci V; Nordström L; Conrotto P; Ek S Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780 [TBL] [Abstract][Full Text] [Related]
38. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697 [TBL] [Abstract][Full Text] [Related]